Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,309
Closed -$7.81M 3844
2025
Q3
$7.81M Buy
+25,309
New +$7.93M 0.03% 478
2024
Q4
Sell
-1,556
Closed -$362K 3051
2024
Q3
$362K Buy
+1,556
New +$320K ﹤0.01% 1731
2024
Q2
Sell
-4,091
Closed -$701K 2908
2024
Q1
$701K Buy
+4,091
New +$763K ﹤0.01% 1072
2023
Q4
Sell
-6,182
Closed -$985K 2917
2023
Q3
$985K Buy
+6,182
New +$1.38M 0.01% 986
2023
Q1
Sell
-16,636
Closed -$4.9M 3039
2022
Q4
$4.9M Sell
16,636
-594
-3% -$164K 0.07% 270
2022
Q3
$3.95M Buy
17,230
+13,129
+320% +$3.29M 0.04% 366
2022
Q2
$893K Sell
4,101
-3,496
-46% -$795K 0.01% 1036
2022
Q1
$2.02M Buy
7,597
+1,787
+31% +$439K 0.01% 634
2021
Q4
$1.54M Buy
+5,810
New +$1.69M 0.01% 810
2021
Q3
Sell
-24,693
Closed -$6.78M 3655
2021
Q2
$6.78M Buy
24,693
+19,493
+375% +$5.3M 0.06% 248
2021
Q1
$1.36M Buy
+5,200
New +$1.39M 0.01% 862
2020
Q2
Sell
-7,211
Closed -$1.19M 1717
2020
Q1
$1.19M Buy
+7,211
New +$1.32M 0.08% 227
2019
Q2
Sell
-4,808
Closed -$457K 878
2019
Q1
$457K Buy
+4,808
New +$412K 0.07% 201

Other funds holding PODD

HRT Financial's PODD Position: Q4 2025 in Review

HRT Financial sold out of Insulet (PODD) in Q4 2025, closing a stake of 25,309 shares — an estimated $7.81M sold.

HRT Financial first reported a position in PODD in Q1 2019 and held it in 13 quarters. The position peaked at $7.81M in Q3 2025. 832 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

  • HRT Financial reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 25,309 Insulet shares in Q4 2025, an estimated $7.81M.
  • HRT Financial first reported a position in Insulet in Q1 2019 and held it in 13 quarters.
  • HRT Financial's Insulet position peaked at $7.81M in Q3 2025.
  • 832 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.